Please wait
0001389545 EX-FILING FEES Other 0001389545 2025-10-03 2025-10-03 0001389545 1 2025-10-03 2025-10-03 0001389545 2 2025-10-03 2025-10-03 0001389545 3 2025-10-03 2025-10-03 0001389545 4 2025-10-03 2025-10-03 0001389545 5 2025-10-03 2025-10-03 0001389545 6 2025-10-03 2025-10-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Table

 

FORM S-3

(Form Type)

 

NovaBay Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

   Security Type  Security
Class Title
  Fee
Calculation
Rule or
Instruction
   Amount
Registered
   Proposed
Maximum
Offering Price
Per Unit
   Maximum
Aggregate
Offering Price
   Fee Rate   Amount of
Registration
Fee
 
Newly Registered Securities
Fees to be paid  Equity  Common Stock   Rule 457(o)    (1)   (1)             - 
Fees to be paid  Equity  Preferred Stock   Rule 457(o)    (1)   (1)             - 
Fees to be paid  Debt  Debt Securities   Rule 457(o)    (1)   (1)             - 
Fees to be paid  Other  Warrants   Rule 457(o)    (1)   (1)             - 
Fees to be paid  Other  Units   Rule 457(o)    (1)   (1)             - 
                                     
Fees to be Paid  Unallocated (Universal) Shelf  All of the Above   Rule 457(o)   $(1)   (1)  $200,000,000(2)  $0.0001531   $30,620 
Fees Previously Paid  -  -   -    -    -    -    -    - 
   Total Offering Amounts             $200,000,000        $30,620 
   Total Fees Previously Paid                        - 
   Total Fee Offsets                       $- 
   Net Fee Due                       $30,620 

 

 

(1) In accordance with Rule 457(o), the table omits the amount to be registered and the proposed maximum offering price per unit for each class of security. These will be determined, from time to time, by the Registrant in connection with the issuance of the securities registered hereunder.
(2) Represents the proposed maximum aggregate offering price of securities that may be sold under this registration statement.